Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Globus Medical earnings beat by $0.02, revenue topped estimates

Published 20/02/2024, 23:31
GMED
-

Investing.com - Globus Medical (NYSE: GMED) reported fourth quarter EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $616.53M versus the consensus estimate of $608.17M.

Guidance

Globus Medical sees FY 2024 EPS of $2.68-$2.70 versus the analyst consensus of $2.70.

Globus Medical sees FY 2024 revenue of $2.45M-$2.48M versus the analyst consensus of $2.48M.

Globus Medical's stock price closed at $54.16. It is up 16.93% in the last 3 months and down -8.41% in the last 12 months.

Globus Medical saw 3 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See Globus Medical's stock price’s past reactions to earnings here.

According to InvestingPro, Globus Medical's Financial Health score is "great performance".

Check out Globus Medical's recent earnings performance, and Globus Medical's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.